Safety and feasibility of estrogen receptor-β targeted phytoSERM formulation for menopausal symptoms: Phase 1b/2a randomized clinical trial

Lon S. Schneider, Gerson Hernandez, Liqin Zhao, Adrian A. Franke, Yu Ling Chen, Sonia Pawluczyk, Wendy J. MacK, Roberta D. Brinton

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and feasibility of estrogen receptor-β targeted phytoSERM formulation for menopausal symptoms: Phase 1b/2a randomized clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences